FENNEC PHARMACEUTICALS INC. — Form 4
Filed August 31, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 46/100
What the filing says
Chief Medical Officer Sayad Pierre Sargis (FENC) sold 12K shares (~$146K) on the open market (56% of holdings). Large sale — ~56% of holdings.
Why this rating
Large sale — ~56% of holdings.
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.